Quality criteria for in vitro human pluripotent stem cell-derived models of tissue-based cells

The advent of the technology to isolate or generate human pluripotent stem cells provided the potential to develop a wide range of human models that could enhance understanding of mechanisms underlying human development and disease. These systems are now beginning to mature and provide the basis for the development of in vitro assays suitable to understand the biological processes involved in the multi-organ systems of the human body, and will improve strategies for diagnosis, prevention, therapies and precision medicine. Induced pluripotent stem cell lines are prone to phenotypic and genotypic changes and donor/clone dependent variability, which means that it is important to identify the most appropriate characterisation markers and quality control measures when sourcing new cell lines and assessing differentiated cell and tissue culture preparations for experimental work. This paper considers those core quality control measures for human pluripotent stem cell lines and evaluates the state of play in the development of key functional markers for their differentiated cell derivatives to promote assurance of reproducibility of scientific data derived from pluripotent stem cell-based systems.

PISTOLLATO Francesca;  PRICE Anna;  COECKE Sandra;  PARVATAM Surat;  PAMIES David;  KATHERINE Czysz;  HAO Jie;  KEE Kehkooi;  KEE KEONG TEO Adrian;  SHUAISHUAI Niu;  WILMES Anja;  SMIRNOVA Lena;  FREUND Christian;  MUMMERY Christine;  STACEY Glyn; 

2022-09-23

PERGAMON-ELSEVIER SCIENCE LTD

JRC129204

0890-6238 (online),   

https://www.sciencedirect.com/science/article/pii/S0890623822000880,    https://publications.jrc.ec.europa.eu/repository/handle/JRC129204,   

10.1016/j.reprotox.2022.06.003 (online),